Mike Gandy

Mike Gandy Email and Phone Number

Partner | CFO @ FLG Partners
Texas, United States
Mike Gandy's Location
Dallas-Fort Worth Metroplex, United States, United States
About Mike Gandy

Senior level Chief Financial Officer with over 25 years of senior financial management experience and over 30 years dedicated to the MedTech sector, focusing on developmental and commercial stage companies in women’s health, gynecology, urology, cardiology, and orthopedics.Broad operational foundation in Marketing, Strategic Planning, Cost Accounting, Human Resources, and Information Systems has enabled me to work effectively across traditional functional boundaries. I bring value by integrating financial management expertise with my understanding of how successful businesses thrive to create an environment of teamwork, thereby breaking down organizational impediments to better achieve financial and operating objectives. While focusing primarily on venture funded, developmental stage companies, I've raised nearly $150M in a combination of equity and debt, in mostly early stage raises.Contact me at: mgandy@flgpartners.com

Mike Gandy's Current Company Details
FLG Partners

Flg Partners

View
Partner | CFO
Texas, United States
Website:
flgpartners.com
Employees:
44
Mike Gandy Work Experience Details
  • Flg Partners
    Partner | Cfo
    Flg Partners
    Texas, United States
  • Mosaic Diagnostics
    Chief Financial Officer
    Mosaic Diagnostics Dec 2021 - Present
    Overland Park, Kansas, Us
    Mosaic Diagnostics LLC is a diagnostic testing laboratory which seeks to uncover powerful insights into the root cause of underlying illness with simplified, science-driven testing. These tests bring clarity to complex health conditions and provides the tools to create personalized treatment protocols.
  • Flg Partners
    Partner | Cfo
    Flg Partners 2019 - Present
    Palo Alto, Ca, Us
    Founded in 2004, FLG Partners is a financial consulting and advisory practice of experienced CFOs delivering to CEOs and Boards, high-value, interim and permanent leadership – exclusively at the C-level. FLG partners provide companies with experienced financial leaders to help them solve their toughest problems, navigate through near term inflexion points, evaluate their strategic options and make better business decisions. Our clients come to us when they need both immediate and long term solutions – from ramping for growth to preparing for flex points. Our financial and board advisory practice spans hundreds of client engagements across industry sectors, delivering a comprehensive range and depth of CFO leadership, capabilities and expertise. Whether your needs are for growth, fundraising, M&A, restructuring, scaling your business operations or board support, we’re your solution.
  • Dna Diagnostics Center
    Chief Financial Officer
    Dna Diagnostics Center Mar 2019 - Nov 2021
    Fairfield, Oh, Us
    DNA Diagnostics Center (DDC) is a world class lab focused on the testing of DNA for a variety of applications including legal, paternity, lifestyle and forensics. DDC was acquired by Eurofins in August of 2021
  • Spinal Kinetics, Inc.
    Chief Financial Officer
    Spinal Kinetics, Inc. Jan 2016 - Jan 2019
    Spinal Kinetics is a wholly owned subsidiary of Orthofix. Formerly a privately-held, commercialization stage medical device company, Spinal Kinetics develops innovative and practical motion preservation systems for treating degenerative diseases of the spine. Orthofix acquired Spinal Kinetics in April of 2018 and is actively integrating the Company into the Orthofix family.
  • Invuity, Inc.
    Chief Financial Officer
    Invuity, Inc. Jan 2013 - Aug 2015
    Invuity (IVTY - NASDAQ) develops and markets technologically advanced visualization solutions for minimally invasive surgery by providing physicians with the illumination where it's needed most - inside the incision.Our products are engineered with sophisticated optical technology to enable less invasive surgery by providing brilliant illumination in deep surgical cavities. Less glare, fewer shadows, and the diffuse lighting of the incision provide for better overall visualization.
  • Novasys Medical, Inc.
    Vp Finance And Cfo
    Novasys Medical, Inc. Jul 2010 - Jan 2013
    Novasys has developed and is now commercializing the Renessa, a non-surgical, office based treatment for women suffering from Stress Urinary Incontinence. There are no incisions, bandages or dressings required. Recovery is rapid and comfortable, with minimal post-procedure limitations.Using radiofrequency (RF) energy and trans-urethral access to treat multiple sites in the lower urinary tract, the Renessa offers women an attractive non-surgical solution to a condition which effects nearly 15 million women in the U.S. alone.
  • Baxano, Inc.
    Chief Financial Officer
    Baxano, Inc. Sep 2009 - Jul 2010
    Baxano is focused on the development of an instrument and method to treat lower spine compression in an innovative and tissue-saving manner.
  • Bacchus Vascular
    Vice President, Finance And Chief Financial Officer
    Bacchus Vascular Sep 2008 - Sep 2009
    Us
    Bacchus Vascular, Inc. is a privately held medical device company dedicated to the treatment of peripheral vascular disease. Deep Vein Thrombosis (DVT) is a blood disorder resulting from the formation of a blood clot (thrombus) inside a deep vein of the leg, commonly located in the calf or thigh. DVT occurs when the blood clot either partially or completely blocks the flow of blood in the vein. Patient symptoms include pain, swelling, and discoloration. Approximately 600,000 new DVT cases are diagnosed each year in the United States with as many as 20 million patients having had a prior DVT. The majority of patients diagnosed with DVT are treated with medication therapy alone. While this therapy reduces the risk of fatal Pulmonary Embolism and further blood clot from forming, the underlying blood clot may remain and result in permanent vein damage and the development of Post Thrombotic Syndrome.Bacchus Vascular was acquired in March of 2009 by Covidien. The terms were not disclosed. I will stay on into the 4th quarter of 2009 to ensure a successful transition.
  • Lipid Sciences, Inc.
    Corporate Controller
    Lipid Sciences, Inc. Apr 2007 - Aug 2008
    A closely held, public company, Lipid Sciences developed medical devices and innovative peptides which sought to remove lipids from cholesterol molecules within the bloodstream. Ultimately, this treatment was intended to reverse the atherosclerosis process. Heading up the SEC reporting and SOX compliance effort, I was also responsible for all finance and accounting functions.
  • Kerberos Proximal Solutions, Inc.
    Corporate Controller
    Kerberos Proximal Solutions, Inc. Mar 2006 - Dec 2006
    Kerberos developed, manufactured, and commercialized the Rinsperator, a clever catheter based thrombectomy device used in the peripheral arterial system to remove blood clots. Physicians would thread the catheter over the clot, inflate a balloon distal to the treatment point, and then inject a saline solution to the treated area. The resulting 'rinsing' effect would break up the clot, allowing for the removal of the clot via aspiration.The Company was acquired in September of 2006 by FoxHollow, and I remained through the end of the year to assist with the transition.
  • Surx, Inc.
    Chief Financial Officer
    Surx, Inc. Oct 1997 - May 2006
    SURx, Inc., a venture funded Medical Device company, developed and commercialized an innovative product utilizing Radio Frequency energy to allow physicians to treat female stress urinary incontinence in an out-patient setting. The Company's first two products accessed the female endopelvic faschia via two distinct methods: laprascopic and transvaginal approaches. Cleared by the FDA in 2001, the products were immediately marketed using a direct sales force throughout multiple metropolitan areas. The products were sold to CooperSurgical in 2003 in an asset sale.The Company changed its name to Solarant Medical and continued effort to develop a device which sought to treat the same tissue without the use of an incision. The Company was acquired by American Medical Systems in May of 2006.
  • Advanced Cardiovascular Systems, Inc.
    Manager Of Financial Planning And Analysis
    Advanced Cardiovascular Systems, Inc. Aug 1994 - Oct 1997
    ACS was a pioneer in the treatment of cardiovascular disease through the use of minimally invasive interventional devices such as balloon dilation catheters and cororary stents. The Company was originally a division of Eli Lily's Medical Device Division and was spun off as the Vascular Intervention division of Guidant in 1994.As the head of the Financial Planning and Analysis group, I was responsible to successfully develop and administer the Annual Operating Plan and the Strategic Plan for the $500M division of Guidant Corp.
  • Advanced Cardiovascular Systems, Inc.
    Market Research And Strategic Planning Manager
    Advanced Cardiovascular Systems, Inc. Aug 1992 - Aug 1994
    I directed a staff of five which managed the company’s Strategic Planning process, and helped drive the organization during period of intense corporate and environmental change. I conducted various market surveys, conjoint analyses, focus groups, and other market research to understand product performance, and better evaluate product concepts.
  • Advanced Cardiovascular Systems, Inc.
    Department Head Of Manufacturing Analysis And Information
    Advanced Cardiovascular Systems, Inc. Jan 1988 - Aug 1992
    Supervised a group of four analysts responsible for determining the Manufacturing Cost of Product Sold, and for providing financial analyses used in make/buy decisions within Manufacturing.
  • Rockwell International, Inc.
    Various Finance And Operations Positions
    Rockwell International, Inc. Apr 1983 - Dec 1987
    Autonetic Strategic Systems Division - Anaheim, CAComputer functional Systems Analyst – Member of Business Systems Modernization team.Quest Program Participant – 16 month high potential training rotation through operations.Program Cost Analyst – Provided material, labor, and other financial projections

Mike Gandy Skills

Medical Devices Fda Strategy Management Start Ups Product Management Strategic Planning Cross Functional Team Leadership Mergers And Acquisitions Manufacturing Leadership Financial Analysis Business Strategy Product Launch Analysis Business Development Commercialization Biotechnology Executive Management Ipo New Business Development

Mike Gandy Education Details

  • California State University, Fullerton
    California State University, Fullerton
    Masters Of Business Administration
  • California State University, Long Beach
    California State University, Long Beach
    Finance

Frequently Asked Questions about Mike Gandy

What company does Mike Gandy work for?

Mike Gandy works for Flg Partners

What is Mike Gandy's role at the current company?

Mike Gandy's current role is Partner | CFO.

What is Mike Gandy's email address?

Mike Gandy's email address is mi****@****ers.com

What is Mike Gandy's direct phone number?

Mike Gandy's direct phone number is +140863*****

What schools did Mike Gandy attend?

Mike Gandy attended California State University, Fullerton, California State University, Long Beach.

What are some of Mike Gandy's interests?

Mike Gandy has interest in Collecting Antiques, Exercise, Home Improvement, Shooting, Reading, Gourmet Cooking, Sports, The Arts, Home Decoration, Cooking.

What skills is Mike Gandy known for?

Mike Gandy has skills like Medical Devices, Fda, Strategy, Management, Start Ups, Product Management, Strategic Planning, Cross Functional Team Leadership, Mergers And Acquisitions, Manufacturing, Leadership, Financial Analysis.

Who are Mike Gandy's colleagues?

Mike Gandy's colleagues are Ciara Williams, Chris Cook, Patrick Nugent, Iddrisu A Bass Saviour Kabore, John Supan, Birgitte Sørensen, Bern Whitney.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.